Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
626.00    -3.00 (-0.48%)
Bid:
624.00
Ask:
626.00
Spread: 2.00 (0.321%)
Market Cap: £1.15b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

15 Oct 2020 07:00

RNS Number : 1183C
Volex PLC
15 October 2020
 

15 October 2020

 

Volex plc

("Volex" or the "Company")

 

Trading Update

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is today issuing a trading update ahead of the scheduled announcement of the group's interim results for the 26 weeks ended 4 October 2020, on 12 November 2020. 

COVID-19

 

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remain our principal responsibility and we are providing our facilities with our full support, following all public health advice, and complying with all government directives. All manufacturing facilities remained fully operational following adaptations that were made in the first quarter in response to the COVID-19 pandemic.

 

Trading

 

Volex's performance has continued to improve since the group last updated the market at our Annual General Meeting on 30 July 2020.

 

Consequently, the board now expects revenue and profitability to be above current market expectations for both the half-year period and the full year as a whole.

 

· Unaudited revenue for the six months ended 4 October 2020 is expected to be at least $200 million, which represents an increase of 2.2 per cent over the same period a year earlier;

 

· Underlying operating profit is expected to be at least $20 million, which represents an increase of 25.8 per cent over the same period a year earlier;

 

· Net cash excluding lease liabilities as at 2 October 2020 was approximately $31 million.

 

Executive Chairman Nat Rothschild commented:

 

"We enter the final quarter of calendar 2020 in a healthy position. Our geographic and customer diversification continues to provide the business with a high degree of visibility at this time while ongoing demand for consumer electronics remains strong and the global shift to electric vehicles gathers pace.

 

Absent another widespread COVID-19 related global lockdown, given the robust performance in the first half of the year, coupled with our strong forward order book position, the board expects to see a strong performance for the year as a whole that will be above current market expectations.

 

I would like to extend my sincere thanks to the entire Volex team for their invaluable contribution to this strong performance as we look ahead to the second half of the year with cautious optimism." 

 

For further information please contact:

 

Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman

 

Daren Morris, Chief Financial Officer

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

 

Jack Holden

 

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

Iqra Amin

 

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Nick Lovering

 

 

 

NOTES TO EDITORS:

Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies. For more information please visit www.volex.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFEFILESSEIS
Date   Source Headline
7th May 201310:47 amRNSConfirmation of Preliminary Results Date
11th Apr 20137:00 amRNSTrading Statement
14th Mar 20137:00 amRNSDirector/PDMR Shareholding
18th Feb 20134:15 pmRNSDirector/PDMR Shareholding
15th Feb 20138:59 amRNSDirector/PDMR Shareholding
13th Feb 20132:01 pmRNSDirector/PDMR Shareholding
12th Feb 20137:00 amRNSInterim Management Statement
14th Dec 20127:00 amRNSTrading Update and Board Appointments
10th Dec 20127:00 amRNSDirectorate Changes
5th Dec 201212:44 pmRNSTR-1: Notification of Major Interest in Shares
3rd Dec 20129:19 amRNSDirector PDMR Shareholding
31st Oct 20124:55 pmRNSFull Year Earnings Expectation
31st Oct 20127:00 amRNSHalf-year results
19th Sep 20128:50 amRNSDirector PDMR Shareholding
18th Sep 20127:00 amRNSTrading Update
27th Jul 201211:08 amRNSDirector PDMR Shareholding
27th Jul 20127:00 amRNSVoting Results of 2012 Annual General Meeting
26th Jul 20127:00 amRNSInterim Management Statement
29th Jun 20123:33 pmRNSDirector PDMR Shareholding
25th Jun 20123:21 pmRNSAnnual Report
31st May 20129:05 amRNSDividend currency election
29th May 201212:10 pmRNSCORRECTION - Director PDMR Shareholding
29th May 201211:45 amRNSDirector PDMR Shareholding
29th May 20127:00 amRNSPreliminary Announcement of the Group Results
12th Apr 20127:00 amRNSTrading Update
20th Mar 20123:11 pmRNSDirector Declaration
15th Feb 20124:12 pmRNSNotification of Major Interest in Shares
9th Feb 20127:00 amRNSInvestor Seminar
3rd Feb 201210:35 amRNSDirector/PDMR Shareholding
30th Jan 201212:03 pmRNSDirector/PDMR Shareholding
25th Jan 20124:46 pmRNSDirector PDMR Shareholding
19th Jan 20123:16 pmRNSDirector PDMR Shareholding
17th Jan 201211:56 amRNSDirector/PDMR Shareholding
17th Jan 20127:00 amRNSDirector PDMR Shareholding
13th Jan 20127:00 amRNSIMS for the 15 weeks ended 13 January 2012
9th Nov 20117:00 amRNSAppointment of Joint Broker
2nd Nov 20117:00 amRNSHalf Year Results
21st Oct 20114:36 pmRNSPurchase of Shares by Employees' Share Trust
21st Sep 20112:25 pmRNSTR-1: Notification of Major Interest in Shares
21st Sep 20112:23 pmRNSTR-1: Notification of Major Interest in Shares
15th Sep 20117:00 amRNSTransition to US Dollar reporting
1st Sep 20117:00 amRNSDelisting of Volex plc Preference Shares
11th Aug 20112:18 pmRNSChange of Name
29th Jul 20114:40 pmRNSSecond Price Monitoring Extn
29th Jul 20114:35 pmRNSPrice Monitoring Extension
25th Jul 20115:00 pmRNSVOTING RESULTS OF 2011 AGM
25th Jul 20113:53 pmRNSDirector/PDMR Shareholding
25th Jul 20117:00 amRNSInterim Management Statement
21st Jul 20117:00 amRNSAnnual Information Update
23rd Jun 20117:00 amRNSAnnual Report & Accounts & Notification of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.